Breaking News

YProtech Adds High Potency Capabilities

Marks the second phase of the CRO’s expansion strategy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

YProtech, a contract research organization (CRO) focused on niche chemistry-based services, has installed a high potency facility for the synthesis and manufacture of highly potent cytotoxins for applications in cancer treatment. The CRO relocated to Alderley Park, Cheshire in May 2015 and the installation of a high potency facility marks the second phase of their expansion strategy. The expansion enables YProtech to offer dedicated chemistry services for the non-GMP synthesis and manufacture...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters